Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems

Nuclear export of the influenza virus ribonucleoprotein complex: Interaction of Hsc70 with viral proteins M1 and NS2

(2014) Ken Watanabe et al.   FEBS Open Bio

Specific Nucleoprotein Residues Affect Influenza Virus Morphology

(2013) K. M. Bialas et al.   JOURNAL OF VIROLOGY

Use of baculovirus expression system for generation of virus-like particles: Successes and challenges

(2013) Fuxiao Liu et al.   PROTEIN EXPRESSION AND PURIFICATION

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

(2013) Gale E. Smith et al.   VACCINE

Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity

(2012) Irina Margine et al.   PLoS One

Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture

(2011) Emma Petiot et al.   BMC BIOTECHNOLOGY

Large-scale production and purification of VLP-based vaccines

(2011) Tiago Vicente et al.   JOURNAL OF INVERTEBRATE PATHOLOGY

Baculovirus Capsid Display Potentiates OVA Cytotoxic and Innate Immune Responses

(2011) Paula Molinari et al.   PLoS One

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

(2011) Constantino López-Macías et al.   VACCINE

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes

(2011) Peter Pushko et al.   VACCINE

Baculovirus-Produced Influenza Virus-like Particles in Mammalian Cells Protect Mice from Lethal Influenza Challenge

(2011) Xian-Chun Tang et al.   VIRAL IMMUNOLOGY

Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles

(2011) Vincent Moulès et al.   VIROLOGY

Influenza virus assembly and budding

(2011) Jeremy S. Rossman et al.   VIROLOGY

Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

(2010) Florian Krammer et al.   MOLECULAR BIOTECHNOLOGY

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

(2010) Marc-André D’Aoust et al.   PLANT BIOTECHNOLOGY JOURNAL

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

(2010) Nathalie Landry et al.   PLoS One

Structural organization of a filamentous influenza A virus

(2010) L. J. Calder et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing

(2010) Audrey Le Ru et al.   VACCINE

FluBlok, a next generation influenza vaccine manufactured in insect cells

(2009) Manon M.J. Cox et al.   BIOLOGICALS

Influenza virus-like particle vaccines

(2009) Joel R Haynes   Expert Review of Vaccines

Novel swine-origin influenza A virus in humans: another pandemic knocking at the door

(2009) Martin Michaelis et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Out of Mexico? Scientists Ponder Swine Flu's Origins

(2009) J. Cohen   SCIENCE

Influenza vaccines based on virus-like particles

(2009) Sang-Moo Kang et al.   VIRUS RESEARCH

The Influenza Virus M2 Protein Cytoplasmic Tail Interacts with the M1 Protein and Influences Virus Assembly at the Site of Virus Budding

(2008) B. J. Chen et al.   JOURNAL OF VIROLOGY

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

(2008) Joel R. Haynes et al.   VACCINE